Tissue decellularisation has gained much attention in regenerative medicine as an alternative to synthetic materials. In decellularised tissues, biological cues can be maintained and provide cellular environments still unmet by synthetic materials. Supercritical CO 2 (scCO 2 ) has recently emerged as a promising alternative decellularisation technique to aggressive detergents; in addition, scCO 2 provides innate sterilisation. However, to date, decellularisation with scCO 2 is limited to only a few tissue types with low cellular density.
Introduction
Decellularised tissue matrices closely mimic their 3D native structures and, thus, have a substantial advantage when compared to synthetic materials. The potential of decellularised matrices is well recognised for the replacement of different tissue types (Badylak et al., 2011; Caione et al., 2012; Macchiarini et al., 2008; Patton et al., 2007) . Remarkable success is demonstrated in in vitro experiments in which the tissue function of porcine heart Wainwright et al., 2010) , rat and human kidney and rat lung (Ott et al., 2010; Petersen et al., 2010) can partly be restored after recellularisation of previously decellularised tissues. Moreover, decellularsed matrices are attractive scaffolds for the repair of tendons (Nourissat et al., 2015; Raghavan et al., 2012; Xu et al., 2017) and cartilage (Sutherland et al., 2014; Yang et al., 2010) .
A tissue is considered as decellularised if no visible nuclei remain, less than 50 ng double-stranded DNA per mg extracellular matrix (ECM) dry weight is detected and the DNA fragment length is less than 200 bp (Crapo et al., 2011) . Decellularised matrices are produced by a multistep tissue-specific decellularisation process including lysis of the cell membranes, separation of the cellular components from the ECM, solubilisation of the cytoplasmic and nuclear components and removal of the cellular debris (Aubin et al., 2013) . However, this decellularisation J Antons et al. Decellularisation by supercritical CO 2 process is time-consuming and can compromise the structure and mechanical properties of the tissue (Crapo et al., 2011) . One of the currently most effective decellularisation methods uses perfusion of detergents, such as sodium dodecyl sulphate (SDS), to facilitate removal of cellular material Ott et al., 2010; Petersen et al., 2010; Uygun et al., 2010; Wainwright et al., 2010) . However, this is limited to vascularised tissues. To decellularise denser tissues, e.g. articular cartilage, many steps, such as freeze-thaw, osmotic shock and enzymatic treatment, are required to make the ECM accessible to decellularisation agents. One of the reasons for the long procedure is that this process still relies on the relatively slow diffusion of detergents inside non-or poorly vascularised tissues. Consequently, traces of these detergents might remain inside the tissue and may cause cytotoxicity and adverse effects . Moreover, at the end of the treatment, the decellularised tissues still have to be sterilised, thus introducing an additional step in the protocol. Sterilisation can be achieved by soaking the decellularised tissues in acids or alcohols (Hodde and Hiles, 2002) , ethylene oxide, gamma irradiation (Freytes et al., 2008) or other methods that can further alter the ECM and its mechanical properties (Freytes et al., 2008; Rosario et al., 2008; Sun and Leung, 2008) .
One possibility for integrating both sterilisation and decellularisation in one step while simultaneously overcoming diffusion limitations would be the use of a supercritical fluid as a rinsing agent. A supercritical fluid is a substance at a temperature and pressure higher than its critical point, in which liquid and gas phases cannot be distinguished. Supercritical fluids can diffuse through solids as a gas and dissolve substances as a liquid. This unique behaviour could potentially widely reduce decellularisation time by enhancing the diffusion kinetics. A suitable supercritical fluid for decellularisation is supercritical carbon dioxide (scCO 2 ) since its supercritical point is reached at relatively mild conditions (7.2 MPa/37 °C). Furthermore, scCO 2 can sterilise the sample, having a minor to negligible influence on the tissue structure (Bernhardt et al., 2015) . Nevertheless, scCO 2 itself is apolar, thus, the addition of an entrainer, e.g. ethanol, is necessary to eliminate or counteract charged molecules such as phospholipids (Dunford and Temelli, 1995; Montanari et al., 1999; Tanaka et al., 2004) . Using scCO 2 with ethanol already provides successful decellularisation for aorta, cornea, oesophagus and adipose tissues (Casali et al., 2018; Guler et al., 2017; Halfwerk et al., 2018; Huang et al., 2017; Sawada et al., 2008; Wang et al., 2017; Zambon et al., 2016) . However, when dealing with denser tissues, ethanol does not have the required counteractive solvent strength. Instead of ethanol, CO 2 -philic detergents, such as the commercially available and low-cost Dehypon ® LS-54 (BASF, Ludwigshafen, Germany), could provide the required solvent strength. LS-54 can dissolve bio-macromolecules within scCO 2 and has a solvability as high as 4 weight % due to its four CO 2 -philic propylene oxide groups (Liu et al., 2002) .
This study hypothesis was that the detergent LS-54, in combination with scCO 2 , might be beneficial for decellularisation of dense tissues. Thus, the purpose of the study was to determine whether the treatment of high density tissues, including articular cartilage, tendon and skin, with a CO 2 -philic detergent and a rinsing step in scCO 2 might create a decellularised tissue showing: (i) effective removal of immunological material (visual cell nuclei and DNA), (ii) mechanical and structural properties in the range of the native tissues (control) and (iii) the ability to support cellular growth.
Materials and Methods
Each of the tissues was treated according to the decellularisation procedure summarised in Fig. 1 . The tissue-specific protocol and all characterisation techniques are detailed in this section. All products used in the experiments were purchased from SigmaAldrich unless mentioned otherwise.
Pre-treatment
Cartilage Bovine articular cartilage was obtained from a local slaughterhouse and immediately processed on ice to avoid degradation. The cartilage was carefully harvested from the femoral condyles using an 8 mm biopsy punch and a scalpel to create a cylindrical shape. The bone-facing part of the cartilage was removed with a razor blade and a custom-made guide, leaving a uniform 3 mm-thick cylindrical sample. Afterwards, the cartilage cylinders were thoroughly rinsed in phosphate-buffered saline (PBS), dried with a paper towel and stored at − 80 °C until further use. As the first tests revealed that it was impossible to completely decellularise cartilage and skin with scCO 2 and detergent only in the autoclave available for the study, additional pre-treatment steps were introduced.
The pre-treatment of cartilage consisted of several steps (Fig. 1) . First, 6 freeze-thaw cycles at − 80 °C for 2 h (including the initial storage at − 80 °C) and, then, at 37 °C for 1 h were performed. Next, the samples were treated with 0.05 % trypsin-EDTA (25300062; Life Technologies) at 37 °C for 24 h. Subsequently, the samples were exposed to an osmotic shock by placing them in hypertonic buffer solution (1.5 M NaCl in 10 mM Tris-HCL, pH 8) for 4 h followed by a hypotonic solution (10 mM Tris-HCL, pH 7.6) for 20 h. Then, the cartilage was immediately treated according to the section "scCO 2 treatment".
Tendons
Horse superficial digital flexor tendons were purchased from a local slaughterhouse and processed frozen, to avoid degradation, into 2 mm-thick slices using a diamond band saw (Exakt Technologies, www.ecmjournal.org Oklahoma City, Oklahoma, USA). Then, tendons were dried with a paper towel and stored at − 80 °C until further use.
Skin
Human skin was obtained from the DAL/CHUV biobank (Lausanne, Switzerland), under anonymous donation, in accordance with its regulation and approval by the Institutional Biobank (Lausanne, Switzerland). The human skin was immediately cut into pieces of approximately 15 × 15 mm, dried with a paper towel and stored at − 80 °C until further use. To start the decellularisation procedure, skin was pre-treated with 1 M NaCl for 24 h prior to careful removal of the epidermis with forceps. Then, the skin was immediately treated according to the section "scCO 2 treatment". scCO 2 treatment Based on the protocols described by others (Guler et al., 2017; Huang et al., 2017; Sawada et al., 2008; Wang et al., 2017) , scCO 2 was used to eliminate cellular components from the tissues (Fig. 1) . A modification of these protocols was carried out by pre-saturating the tissues in a CO 2 -philic detergent instead of using ethanol as entrainer to add polarity to CO 2 . Briefly, all tissues were washed for 24 h in a solution of 2 % LS-54 (Dehypon ® , BASF, Ludwigshafen, Germany) under vigorous shaking at 37 °C. Then, the detergentsaturated tissues were individually sealed inside sterilisation bags (Medline Industries, Northfield, Illinois, USA) and placed in an autoclave (SITEC AG, Maur, Switzerland) for 1 h. 99.9 % pure CO 2 was introduced into the pressure vessel (volume of vessel: 4 L), then, pressure was increased to 25 MPa using a high-pressure pump. The temperature was adjusted to 37 °C, but the temperature fluctuated between 31-37 °C due to an imprecise temperature controller, which was conceived for higher temperatures (up to 350 °C). Later, the pressure vessel was rapidly depressurised using a manual valve at a depressurisation rate of approximately ~ 10 MPa/ min. To remove residual detergent, the samples were washed in PBS under vigorous agitation for 24 h while changing the PBS every 8 h. under agitation at 750 rpm overnight or until no visible tissue material remained. The resulting digest was purified by phenol : chloroform : isoamylalcohol (25 : 24 : 1, v/v). The aqueous phase was ethanolprecipitated on ice for 30 min. After centrifugation (16,000 ×g, 10 min, 4 °C), the DNA pellet was washed and reconstituted in nuclease-free water. Subsequently, the DNA content was quantified using a NanoDrop spectrophotometer (Thermo Fisher Scientific). Each sample condition (control and LS-54) was measured in quadruplicate.
GAG quantification S u l p h a t e d G A G s w e r e q u a n t i f i e d b y 1,9-dimethylmethylene blue dye (DMMB) assay. Chondroitin sulphate dilutions from 0 to 100 μg were used to create a standard curve. 100 μL per well of papain-digested tissues at 6 mg dry tissue/ mL were pipetted into a 96-well plate in triplicates. Then, the absorbance was measured on a microplate reader (Wallac 1420 Victor2, PerkinElmer) at a wavelength of 595 nm. Afterwards, chondroitin sulphate concentrations were plotted against absorbance creating a standard curve to determine the GAG concentration in the tissue samples. Each sample condition (control and LS-54) was measured in triplicate.
Mechanical and structural characterisation Scanning electron microscopy (SEM)
To compare the ultrastructure of the tissue before and after the decellularisation treatment, SEM images were acquired. First, the tissues were fixed for 1 h with 1.25 % glutaraldehyde and 1 % tannic acid in a 0.1 M phosphate buffer, pH 7.4. Then, they were washed in PBS and fixed again in 1.0 % osmium tetroxide in PBS for 30 min. Next, tissues were dehydrated in a graded alcohol series followed by critical point drying (CPD300, Leica Microsystems). Subsequently, the samples were coated with a 4 nmthick layer of osmium using an osmium plasma coater (OPC60, Filgen, Japan). SEM sample preparation and imaging were performed at the EPFL BioEM facility, Lausanne, Switzerland. Images were acquired on a scanning electron microscope (Merlin SEM, Zeiss) at two magnifications, 5,000× and 43,800×, with an accelerating voltage of 1.5 and 1.2 kV, respectively. Articular cartilage was imaged from the superficial layer (top view), tendons from the top and skin from the cross-section. Each sample condition (control and LS-54) was imaged in triplicate.
Compression and tension tests: cartilage
To assess the difference in elastic modulus between native (control) and decellularised samples (cECM), an unconfined compression test was performed on a uniaxial test system (Instron E3000, Norwood, Massachusetts, USA; load cell: 3 kN). Briefly, each cartilage cylinder (8 mm diameter, 3 mm height) was compressed to 20 % strain at a compression rate of 200 µm/s. The elastic modulus was determined from
Biological characterisation Histology and immunohistochemistry
To qualitatively assess the removal of cellular material and ECM components, histological sections of native (control) and decellularised tissues (cartilage: cECM; tendon: tECM; skin: sECM) were compared. Briefly, all samples were fixed in 4 % paraformaldehyde and dehydrated in a graded series of ethanol. Samples were embedded in paraffin, sectioned with a microtome to a thickness of 5 μm and stained following standard histology protocols. To stain and visualise any possible remaining cell nuclei, a haematoxylin and eosin dye (H&E) and 4′,6-diamidino-2-phenylindole (DAPI) staining was used. Glycosaminoglycans (GAG) and collagen (COL) were visualised with alcian blue and picrosirius red dyes, respectively.
T o e va l u a t e t h e p r e s e r va t i o n o f c e l l adhesion molecules after decellularisation, immunohistochemistry for fibronectin and laminin was performed. Briefly, 5 μm sections of paraffinembedded samples were de-paraffinised, rehydrated in PBS and permeabilised with a solution of 0.25 % Tween-20 in PBS for 10 min. To expose the ECM molecule's epitopes, samples were digested for 10 min at 37 °C with 4 mg/mL pepsin in 0.01 M HCl. Fibronectin was detected by immunofluorescence, whereas laminin was detected by a peroxidase reaction. Thus, to detect laminin, an additional step to block endogenous peroxidases by Bloxall solution for 10 min was introduced (Bloxall, SP-6000, Vectorlabs, Burlingame, California, USA). To block non-specific antigens, sections prepared for both fibronectin and laminin labelling were treated with 1 % bovine serum albumin solution in PBS at room temperature for 30 min. Laminin was detected by a peroxidase reaction using a polyclonal primary antibody against laminin (1 : 200; L9393) overnight at 4 °C. This was followed by incubation with one drop per section of the horseradish peroxidase (HRP) labelled secondary goat anti-rabbit antibody (ImmPRESS™ HRP antirabbit, MP-7401, Vectorlabs). Subsequently, laminin was detected by adding ImmPACT DAB peroxidase (HRP) substrate (SK-4105, Vectorlabs).
Fibronectin was detected by immunofluorescence by using a monoclonal primary antibody against fibronectin (1 : 200; 610077, BD Biosciences) overnight at 4 °C. This was followed by incubation with Alexa Fluor 568 labelled secondary donkey anti-mouse antibody (1 : 100; A10037, Invitrogen) at ambient temperature for 2 h. Tissue sections were examined under a widefield microscope (DM 5500, Leica) (n = 3 for control and LS-54).
DNA quantification
To assess total DNA content, samples were dried overnight in an oven at 65 °C and the dry weight was recorded. Then, the samples were thoroughly digested in papain buffer [100 mM Na 2 HPO 4 , 100 mM ethylenediaminetetraacetic acid (EDTA), 10 mM cysteine-HCl, 250 µg papain/mL, pH 6.5] at 65 °C www.ecmjournal.org the stress-strain curve between 5 and 15 % of strain. The control cartilage was taken from the − 80 °C freezer prior to the compression test and equilibrated to ambient temperature in PBS for 4 h. Each sample condition (control and LS-54) was measured in quadruplicate.
Compression and tension tests: tendon
Biomechanical testing of tendons was performed on a uniaxial test system (Instron E3000, Norwood, Massachusetts, USA; load cell: 3 kN). The samples (2 mm thickness, 50 mm length, 12 mm width) were placed between two standard tensile test clamps: one portion was attached to the upper clamp and the other end to the lower clamp with an initial tendon free length of 20 mm. An elongation rate of 0.1 mm/s was applied. The control tendon was taken from the − 80 °C freezer prior to the tension test and equilibrated to ambient temperature in PBS for 4 h. Each sample condition (control and LS-54) was measured in quadruplicate.
Compression and tension tests: skin
Skin was not mechanically characterised due to its limited load-bearing function.
Biocompatibility

Zone of inhibition assay
To evaluate the biocompatibily of the decellularised tissues, a Zone of Inhibition (ZoI) assay was performed. Thus, the decellularised samples were tightly fixed into a 35 mm cell culture dish using a custom-made stainless-steel clamp. The size of the samples were 8 mm diameter and 3 mm depth for the cartilage plugs, 15 × 12 × 2 mm for tendon and 15 × 15 × 2 mm for skin. The bovine chondrocytes used for the biocompatibility tests were previously extracted from fresh bovine articular cartilage tissue using collagenase extraction. Briefly, the cell extraction was conducted for 24 h with 0.6 % collagenase II (Life Technologies) in Dulbecco's modified Eagle's medium (DMEM) in a humidified atmosphere at 37 °C and 5 % CO 2 . Subsequently, DMEM (10 % foetal bovine serum, 2 mM L-glutamine, 100 units/mL penicillin-streptomycin) containing 300,000 bovine chondrocytes (passage 5) was added to the cell culture dish. The cells were cultured in a humidified atmosphere at 37 °C and 5 % CO 2 until full confluence (i.e. 100 %) was reached. A Giemsa dye was applied to stain and visualise the chondrocytes surrounding the material and any possible ZoI. Microscopy images for the Giemsa staining were acquired by a Leica DM5500 microscope and overview images were taken by an Iphone 5s (Apple). Each sample condition (control and scCO 2 /LS-54) was tested in triplicate.
Cell viability
To determine the cell viability, a PrestoBlue™ assay (PrestoBlue™, A13261, Life Technologies) was performed at day 1 and day 7 following the manufacturer's instructions. Briefly, 1 million bovine chondrocytes (passage 5) in 50 μL DMEM were evenly pipetted on top of the tissues and left to attach for 1 h in a humidified atmosphere at 37 °C and 5 % CO 2 . Then, DMEM was added to fully immerse the sample. The medium was changed every other day and at day 1 and day 7 a PrestoBlue™ assay was performed. Therefore, a 10 % mixture of PrestoBlue™ reagent in DMEM was prepared and added to the chondrocytes. After 2 h incubation time, 100 μL supernatant per well was distributed in triplicate in a black 96-well plate. Then, the fluorescence at 595 nm was measured using a microplate reader (Wallac 1420 Victor2, PerkinElmer).
To visualise metabolically active cells on the acellular tissues, a MTT assay (MTT, M6494, Thermo Fisher Scientific) was carried out following the manufacturer's protocol. Thus, 1 million bovine chondrocytes (passage 5) in 50 μL DMEM were evenly pipetted on top of the tissues and left to attach for 1 h in a humidified atmosphere at 37 °C and 5 % CO 2 . Then, DMEM was carefully added to fully immerse the tissues. The medium was changed every other day. At day 7, a MTT assay was performed for 4 h at 37 °C in a humidified atmosphere containing 5 % CO 2 using a 10 % mixture of MTT reagent and DMEM. Next, cell penetration was evaluated by histology, following fixing in 4 % paraformaldehyde and embedding in paraffin. 5 μm-thick sections of the tissues were prepared by a microtome and stained by H&E to visualise cell penetration by staining of cell nuclei. Microscopy images for the MTT assay and cell penetration were acquired by a Leica DM5500 microscope and the overview images were taken by an Iphone 5s (Apple). Each sample condition (control and scCO 2 /LS-54) was tested in triplicate.
Statistics
Statistical analysis was performed using GraphPad Prism (La Jolla, CA, USA) software. Means and standard errors were provided for DNA, GAG quantification and mechanical properties. An unpaired two-tailed student's t-test was used to compare differences between native (control) and decellularised tissues (cECM, tECM, sECM). p ≤ 0.05 was considered statistically significant.
Results
Biological characterisation
Histology H&E staining showed complete removal of cell nuclei from articular cartilage, tendons and skin, whereas trace amounts of broken cell nuclei were detected by DAPI staining (Fig. 2a-c) . Picrosirius red staining showed the conservation of collagen (COL), with no visual difference between the control and decellularised tissues. In contrast, GAG content was severely reduced, as evidenced by alcian blue staining.
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The preservation of important cell adhesion molecules (fibronectin, laminin) was evaluated by immunohistochemistry. Fibronectin and laminin were still present after the decellularisation procedure (Fig. 3) . Articular cartilage was positive for fibronectin in the superficial layer (Fig. 3a, white arrow) , however, after decellularisation, fibronectin was distributed in the entire ECM. In both tendons and skin, fibronectin was abundant around the blood vessels (Fig. 3b,c) . Laminin was present in the pericellular space (Fig.  3a, black arrow) and around the blood vessels (Fig.  3b,c) and in the basal lamina of native (control) skin (Fig. 3c, red arrow) . For the skin (Fig. 3c) , it should be emphasised that the epidermis was removed during the decellularisation procedure and, thus, the basal lamina was not present.
DNA and GAG content DNA content was significantly (*p < 0.05) reduced from 1321 ± 210 ng to 241 ± 45 ng dsDNA/mg dry tissue in cartilage (reduced by 82 ± 3 %), from 1135 ± 262 ng to 378 ± 68 ng dsDNA/mg dry tissue in tendons (reduced by 67 ± 6 %) and from 554 ± 34 ng to 29 ± 0.05 ng dsDNA/mg dry tissue in skin (reduced by 95 ± 0.004 %), compared to the native tissue (Fig. 4a,b) . GAG content was also severely reduced (*p < 0.05) as evidenced by alcian blue staining and quantitative analysis. In cartilage, GAG content was reduced from 294 ± 19 μg to 68 ± 31 µg/mg dry tissue (reduced by 87 ± 6 %). In tendons, GAG content was reduced from 21 ± 3 μg to 6 ± 3 µg/mg dry tissue (reduced by 70 ± 6 %) and in skin from 4 ± 2 μg to 2 ± 0.03 µg/mg dry tissue (reduced by 66 ± 0.4 %), compared to the native tissue (Fig. 4a,b) . Fig. 8 displays the effects of scCO 2 only and of pretreatment on the DNA content of cartilage, tendons and skin. Using scCO 2 only did not show any DNA reduction in cartilage (1453 ± 463 ng DNA/mg dry tissue), tendon (1117 ± 34 ng DNA/mg dry tissue) and skin (637 ± 19 ng DNA/mg dry tissue). Likewise, no visual removal of cell nuclei could be detected by histology (H&E staining). Without a pre-treatment, the DNA content of cartilage was not reduced (1363 ± 87 ng DNA/mg dry tissue), whereas it was Fig. 2 . Histological analysis of tissues before (control) and after decellularisation treatment. Histological sections of (a) bovine cartilage, (b) horse tendon and (c) human skin stained with H&E, DAPI, picrosirius red (SR) and alcian blue (AB) dyes; scale bar: 200 μm (cartilage: cECM; tendon: tECM; skin: sECM). www.ecmjournal.org significantly reduced in tendons (378 ± 68 ng DNA/ mg dry tissue, * p < 0.05) and skin (219 ± 13 ng/mg dry tissue, *p < 0.05). However, removing the epidermis prior to decellularisation could further reduce the DNA content of the skin (29 ± 0.05 ng DNA/mg dry tissue, Fig. 4a,b) and the number of cell nuclei at a visual analysis.
Effect of pre-treatment and scCO 2 only
Mechanical and structural characterisation SEM
The ultrastructure of the tissues was modified by the decellularisation treatment (Fig. 5) . For cartilage (cECM), ECM density appeared particularly low as compared to native tissue (Fig. 5a ). This was evident from the decrease in mass surrounding the collagen network. No visual changes in density were observed for tendons and skin. For all tissues, the orientation and size of the collagen fibres themselves matched the control sample almost identically but showed a somewhat looser arrangement.
Compression and tension test
The decellularisation procedure reduced significantly the elastic modulus of articular cartilage (p < 0.0001) from 12.06 ± 2.14 MPa to 1.17 ± 0.34 MPa (maintaining 14.44 ± 2.81 % of the original elastic modulus) (Fig.  6a) . In contrast, tendon elastic modulus (Fig. 6b) was reduced (p > 0.05) from 126.35 ± 9.79 MPa to 113.48 ± 8.48 MPa (maintaining 88.93 ± 7.47 % of its original elastic modulus) after decellularisation.
Biocompatibility
Consistent growth of bovine chondrocytes in direct proximity to the decellularised tissues indicated no ZoI (Fig. 7, top) . Other specific cells, including tenocytes and skin fibroblasts, showed similar results for each tissue (data not shown).
Chondrocytes were metabolically active and adhered to the surface of all decellularised tissues after 1 week of cell culture, as evidenced by MTT assay (Fig. 7, middle) . The cell penetration of Decellularisation by supercritical CO 2 bovine chondrocytes was limited to the surface of all decellularised tissues types (Fig. 7, middle) . Furthermore, chondrocytes remained viable after 1 week, as seen by a constant fluorescent signal in the PrestoBlue™ assay (Fig. 7, bottom) .
Discussion
The working hypothesis of the present study was that scCO 2 might be optimised to decellularise dense tissues in combination with a CO 2 -philic detergent.
To verify this hypothesis, experiments with scCO 2 on articular cartilage, tendons and skin were performed. Decellularisation with scCO 2 and a CO 2 -philic detergent only, could not achieve a complete decellularisation of cartilage and skin. Thus, additional steps were introduced. For cartilage, an extensive pre-treatment involving freeze-thaw, osmotic shock and enzymatic digestion was needed to achive effective decellularisation. For skin, the pretreatment consisted of removing the epidermis prior to decellularisation.
The described method substantially reduced the cellular material in all dense tissue types tested (Fig.  2a-c) . From a visual inspection, there were virtually no cell nuclei in the H&E staining as compared to the native tissue, which was confirmed by the significantly reduced DNA content (*p < 0.05) (Fig.  4a ). There were only trace amounts of broken cell nuclei visible in the DAPI staining.
For cartilage, a DNA reduction from 1321 ± 210 ng to 241 ± 45 ng dsDNA/mg dry tissue (reduced by 82 ± 3 %) was achieved (Fig. 4a) , compared to the 47.6 ng dsDNA/mg dry tissue (reduced by 94 %) achieved by Bautista et al. (2016) . In tendons, the DNA content was reduced from 1135 ± 262 ng to 378 ± 68 ng dsDNA/mg dry tissue (reduced by 67 ± 6 %) (Fig. 4a)   Fig. 4 . DNA and GAG content before (control) and after treatment (decellularised). (a) Relative (normalised) and absolute DNA content; (b) relative (normalised) and absolute GAG content. *p < 0.05. www.ecmjournal.org as compared to the ~ 100 ng/mg dry tissue (reduced by 90 %) achieved by Xu et al. (2017) . For skin, a reduction from 554 ± 34 ng to 29 ± 0.05 ng dsDNA/ mg dry tissue (reduced by 95 ± 0.004 %) was observed (Fig. 4a) , compared to 40 ng dsDNA/mg dry tissue obtained by Zhang et al. (2016) . It should be noted that the DNA content in the native tissues was higher per mg dry tissue than in the cited studies. This could be due to batch-to-batch variation and differences in the DNA extraction method.
Comparing the absolute DNA content achieved with the technique here described to the threshold defined by Crapo and et al. (2011) , only skin was below the limit of 50 ng dsDNA/mg dry tissue, whereas cartilage and tendons contained substantially more DNA. GAG content was significantly reduced (p < 0.05) in cartilage, in tendons and in skin (Fig. 4b) . This was consistent with previous studies reporting a GAG reduction by 71.0 ± 6.10 % in cartilage (Bautista et al., 2016) and 67 % in tendons (Youngstrom et al., 2013 ) using a SDS-based decellularisation protocol. For skin, 1.56 ± 0.42 µg/mg GAG/dry weight are retained in the decellularised dermis according to Zhang et al. (2016) , being less than what was retained using the here presented protocol. However, Zhang et al. (2016) do not perform any comparison with the native tissue.
It should be noted that decellularisation does not always remove a significant amount of GAGs. For instance, decellularisation of rat hearts with SDS in pulsatile flow retains most of the GAGs in the ECM (Park et al., 2018) . Likewise, optimisation of the decellularisation protocol can significantly enhance the remaining GAG content in a decellularised Illien-Jünger et al., 2016) . GAGs are important for the visco-elastic properties of tissues (Lovekamp et al., 2006) . The GAG reduction was a possible explanation for the looser arrangement of collagen fibres in the ultrastructure of articular cartilage after decellularisation (Fig.  5a) . Therefore, the present study supported the results of Schneider et al. (2016) , who show a looser collagen fibre arrangement in articular cartilage after decellularisation. Moreover, the less dense fibre arrangement results in a higher porosity, which is a potential advantage for the recellularisation of decellularised tissues (Nasrollahzadeh et al., 2017) . The cell adhesion molecules, fibronectin and laminin, were still present in the tissues after the decellularisation procedure (Fig. 3) . Although, it should be noted that laminin was mostly present in close vicinity to blood vessels and in the pericellular space. A comparison of the results of this study with the previously cited decellularisation studies of articular cartilage (Bautista et al., 2016; Schneider et al., 2016) and tendons (Xu et al., 2017; Youngstrom et al., 2013) was not possible, since no immunohistochemistry was performed in these studies. Only in case of the Zhang et al. (2016) study, immunohistochemistry was performed and, similar to the observations of the present study, laminin was detected around the blood vessels. The conservation of cell adhesion molecules after the decellularisation process was a positive result, since cell adhesion molecules are crucial for Decellularisation by supercritical CO 2 the bioactivity of the decellularised tissue. For this reason, cell adhesion molecules (fibronectin, laminin, arginylglycylaspartic-acid-containing molecules and others) are often added to synthetic materials to enhance their bioactivity (Lutolf and Hubbell, 2005; Shin et al., 2003) . Mechanical tests showed that the stiffness of the decellularised tissues was not affected by the treatment in case of tendons but dropped significantly (*p < 0.0001) in articular cartilage (Fig.  6) . These results compared well with other studies in which equine tendons and porcine articular cartilage are decellularised by SDS. For equine tendons, the elastic modulus decreases from 76.13 ± 4.12 MPa to 70.31 ± 5.91 MPa [92.35 ± 8.41 % of the native tendons elastic modulus is maintained (Youngstrom et al., 2013) ]; for porcine articular cartilage, the equilibrium modulus is reduced from 0.145 MPa to 0.035 MPa [maintaining 24.8 ± 2.2 % of the native cartilage properties (Bautista et al., 2016) ]. In the described protocol, the reduction in elastic modulus of the articular cartilage could be caused by the extensive pre-treatment, which removed most GAG molecules from the ECM. A loss of GAGs, which attracts water into the ECM, affects the mechanical properties of tissues through a loss of hydrostatic pressure (Bautista et al., 2016; Maroudas et al., 1969; Maroudas, 1976) . For tendons, the effect of a lower GAG content is less pronounced since tendons only contain between 0.2 % and 5 % GAGs in the tensional zone and in the dry mass at the bone insertion area, respectively (Merrilees and Flint, 1980) . Since tendons mostly work in tension and not in compression, GAG content is less important than in articular cartilage, where 11 % of GAGs in dry mass can be detected (Yu et al., 1997) .
The decellularised tissues were non-cytotoxic to bovine chondrocytes (Fig. 7) and human tenocytes and fibroblasts (data not shown). The biocompatibility was further evidenced by ZoI, MTT and PrestoBlue™ assays after 1 week of culture. The cell penetration of bovine chondrocytes into the decellularised tissues was mostly limited to the surface of the tissue (Fig.  7 , middle) after 1 week of cell culture. However, these tests are only a first indicator for a favourable biocompatibility. More extensive studies attempting to recellularise the obtained decellularised tissues should also be performed for a final confirmation of biocompatibility.
The effect of scCO 2 only and of pre-treatment on the DNA content of cartilage, tendons and skin are displayed in Fig. 8 . scCO 2 only did not reduce the DNA content in any of the three tissues. This was expected since scCO 2 itself is apolar and needs a cosolvent such as ethanol or a CO 2 -philic detergent to remove polar molecules such as phospholipids (cell membrane) or DNA (Dunford and Temelli, 1995; Montanari et al., 1999; Tanaka et al., 2004) . Without pre-treatment, scCO 2 /LS-54 could significantly reduce the DNA content of tendons (p < 0.05). However, to effectively remove DNA content and visual cell nuclei, cartilage and skin required a pre-treatment prior to treatment with scCO 2 /LS-54. It is possible that a pre-treatment of articular cartilage was necessary due to the high density of its ECM with an average pore size of only 6 nm (Maroudas, 1973) . Hence, to effectively remove phospholipids and DNA, a pretreatment to loosen the ECM structure was required for cartilage. Without a pre-treatment, the DNA content of skin was significantly reduced (p < 0.05), but visual cell nuclei remained as displayed in Fig. 8c . Thus, the epidermis was removed prior to treatment with scCO 2 /LS-54.
The present study had also several inherent limitations. Decellularisation of cartilage and skin required a pre-treatment since scCO 2 and CO 2 -philic detergent could not completely decellularise these tissues. The pre-treatment significantly reduced the mechanical properties of articular cartilage. One possible solution to enhance the efficiency of the scCO 2 and CO 2 -philic detergent decellularisation and to avoid these aggressive pre-treatment steps is a modification of the process parameters such as pressure, treatment time, temperature and concentration of detergent. A higher process pressure (not possible with the autoclave used) could help to entirely remove the CO 2 -philic detergent LS-54 by simple rinsing with scCO 2 . With the current protocol, decellularised tissues still contained residual detergent and required an additional washing step in PBS to obtain a high biocompatibility. The detergent Dehypon ® LS-54 is a common household and industrial surfactant, which has a high toxicity for aquatic organisms according to its safety data sheet. Hence, when used for decellularisation, LS-54 should be completely removed to avoid cytotoxicity. In preliminary tests of different doses of LS-54 in DMEM, a concentration as low as 0.01 % demonstrated toxicity on bovine chondrocytes. Living chondrocytes were observed at a concentration of 0.002 % (data not shown). Thus, a complete removal of LS-54 is paramount. Trace amounts of this detergent can be detected by analytical methods such as nuclear magnetic resonance (NMR) (Juanssilfero et al., 2011) . Thus, it would be possible to use NMR to evaluate the successful removal of the detergent LS-54 from the decellularised tissues.
The size of the diverse decellularised tissues was different. This was due to the distinct processing steps of each tissue and different available tissue sources. However, the use of a supercritical fluid should also enable the use of bigger samples since diffusion is largely enhanced.
One aspect that was not verified completely during this study was the sterility of the decellularised tissues after scCO 2 treatment. scCO 2 can be used as a gentle sterilisation technique for tissues (Bernhardt et al., 2015) . For instance, scCO 2 is used to sterilise tendons whereby mechanical properties are maintained (Nichols et al., 2009) . However, if sterility was also achievable with the used protocol was not tested. This should ideally be done after a further www.ecmjournal.org optimisation of the protocol. However, the fact that cells were cultured with the treated matrix for the biocompatibility assay and no contamination was observed would indicate that the matrix was sterile. Despite these limitations, the scCO 2 and CO 2 -philic detergent decellularisation protocol worked well for tendons that were decellularised without any pretreatment, while maintaining most of their mechanical properties. The protocols for skin and cartilage were not perfected yet as additional treatment steps were still necessary for decellularisation; however, there is still room for improvement by using a more powerful autoclave. Also, important cell adhesion molecules such as fibronectin and laminin were preserved in the ECM of all tested tissues after the procedure, an important aspect that was widely neglected in earlier publications. The focus of future experiments should be a further optimisation of the process parameters for all tissues, a substantial reduction of pre-and posttreatment steps for skin and cartilage and complete sterility testing. Taken together, the use of scCO 2 and CO 2 -philic detergent had advantages when compared to established methods for the decellularisation of tendons. With further optimisation of the process parameters, it could also become a true alternative for other dense tissues, including skin and cartilage.
